The astronauts will support several investigations, including ones aiming to create a protein-based artificial retina and evaluate how gut microbes change in space.
The alliance will expand Sanofi's trek into tech-based drug discovery and development platforms.
The San Francisco-based investment firm purchased bswift to propel long-term growth.
The UK-based wearable medical device company plans to use the funds to expand in Europe and North America.
The new allocation will help the company expand its insurance coverage, including Medicare and Medicaid, across the U.S.
A J.D. Power study indicates telehealth is the preferred method among consumers for receiving certain types of medical care.
Rippl's mental health offering aims to provide seniors with 24/7 access to care.
Kaleidoscope, Surge, Optellum, Cionic and Arcascope also announce funding rounds.
Mati Gil, CEO of AION Labs, describes how its new startup OMEC.AI came to fruition and what it aims to accomplish for drug discovery and development.
The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance.
_8_43.jpeg?itok=smxgAxmM "A piggy bank next to a stethoscope and a pile of coins.")
